Evidence for serotonin function as a neurochemical difference between fear and anxiety disorders in humans?

Journal of Psychopharmacology

Volumn 29, Issue 10, 2015, Pages 1061-1069

  Corchs, Felipe ^a   Nutt, David J ^b   Hince, Dana A ^c   Davies, Simon J C ^d   Bernik, Marcio ^a   Hood, Sean D ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

5 Hydroxytryptamine; anxiety; fear; tryptophan depletion

Indexed keywords

SEROTONIN; TRYPTOPHAN; SEROTONIN UPTAKE INHIBITOR;

ADULT; AMINO ACID BLOOD LEVEL; ANXIETY DISORDER; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEAR DISORDER; FEMALE; GENERALIZED ANXIETY DISORDER; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SOCIAL PHOBIA; STATE TRAIT ANXIETY INVENTORY; VISUAL ANALOG SCALE; ANXIETY; ANXIETY DISORDERS; DRUG EFFECTS; FEAR; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ANXIETY; ANXIETY DISORDERS; FEAR; FEMALE; HUMANS; MALE; PANIC; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TRYPTOPHAN;

EID: 84942103461     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881115590603     Document Type: Article

References (40)

1. Andrews G, (2009) Stress-Induced and Fear Circuitry Disorders: Advancing the Research Agenda for DSM-V. 1st ed. Washington, DC: American Psychiatric Association.
2. Andrews G, Anderson TM, Slade T, et al. (2008) Classification of anxiety and depressive disorders: Problems and solutions. Depress Anxiety 25: 274-281.
3. Argyropoulos SV, Hood SD, Adrover M, et al. (2004) Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biol Psychiatry 56: 503-509.
4. Baldwin DS, Anderson IM, Nutt DJ, et al. (2014) Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 Guidelines from the British Association for Psychopharmacology. J Psychopharmacol 28: 403-439.
5. Bell C, Forshall S, Adrover M, et al. (2002) Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. J Psychopharmacol 16: 5-14.
6. Bell C, Hood S, Potokar J, et al. (2011) Rapid tryptophan depletion following cognitive behavioural therapy for panic disorder. Psychopharmacology (Berl) 213: 593-602.
7. Blanchard DC, Hynd AL, Minke KA, et al. (2001) Human defensive behaviors to threat scenarios show parallels to fear- and anxiety-related defense patterns of non-human mammals. Neurosci Biobehav Rev 25: 761-770.
8. Bond A, Lader M, (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47: 211-218.
9. Charney DS, (2004) Psychobiological mechanisms of resilience and vulnerability: Implications for successful adaptation to extreme stress. Am J Psychiatry 161: 195-216.
10. Corchs F, Nutt DJ, Hood S, et al. (2009) Serotonin and sensitivity to trauma-related exposure in selective serotonin reuptake inhibitors-recovered posttraumatic stress disorder. Biol Psychiatry 66: 17-24.
11. Davidson JR, Payne VM, Connor KM, et al. (2005) Trauma, resilience and saliostasis: Effects of treatment in post-traumatic stress disorder. Int Clin Psychopharmacol 20: 43-48.
12. Davies SJ, Hood SD, Argyropoulos SV, et al. (2006) Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders. J Clin Psychopharmacol 26: 414-418.
13. Deakin J, (2013) The origins of €5-HT and mechanisms of defence€™ by Deakin and Graeff: A personal perspective. J Psychopharmacol 27: 1084-1089.
14. Deakin JFW, Graeff FG, (1991) 5-HT and mechanisms of defence. J Psychopharmacol 5: 305-315.
15. Delgado PL, Charney DS, Price LH, et al. (1990) Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47: 411-418.
16. Feinstein JS, Buzza C, Hurlemann R, et al. (2013) Fear and panic in humans with bilateral amygdala damage. Nat Neurosci 16: 270-272.
17. Friedman MJ, Resick PA, Bryant RA, et al. (2011) Classification of trauma and stressor-related disorders in DSM-5. Depress Anxiety 28: 737-749.
18. Goddard AW, Sholomskas DE, Walton KE, et al. (1994) Effects of tryptophan depletion in panic disorder. Biol Psychiatry 36: 775-777.
19. Graeff FG, Zangrossi H Jr,. (2010) The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders. Cent Nerv Syst Agents Med Chem 10: 207-217.
20. Gray JA, Mcnaughton N, (2000) The neuropsychology of anxiety: An enquiry into the functions of septo-hippocampal system. 2nd ed. Oxford: Oxford University Press.
21. Guy W, (1976) ECDEU Assessment Manual for Psychopharmacology. Rockville MD: US Department of Health, Education and Welfare.
22. Harmer CJ, Rogers RD, Tunbridge E, et al. (2003) Tryptophan depletion decreases the recognition of fear in female volunteers. Psychopharmacology (Berl) 167: 411-417.
23. Hood S, (2010) Acute tryptophan depletion in 5 clinical anxiety disorders: PD, SAND, PTSD, GAD & OCD. 1st annual neurotalk, Singapore, 25-28 June 2010.
24. Hood SD, Bell CJ, Nutt DJ, (2005) Acute tryptophan depletion. Part I: Rationale and methodology. Aust N Z J Psychiatry 39: 558-564.
25. Hood SD, Hince DA, Davies SJ, et al. (2010) Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder. Psychopharmacology (Berl) 208: 223-232.
26. Insel T, Cuthbert B, Garvey M, et al. (2010) Research domain criteria (Rdoc): Toward a new classification framework for research on mental disorders. Am J Psychiatry 167: 748-751.
27. Insel TR, (2014) The NIMH Research Domain Criteria (Rdoc) Project: Precision medicine for psychiatry. Am J Psychiatry 171: 395-397.
28. Krueger RF, (1999) The structure of common mental disorders. Arch Gen Psychiatry 56: 921-926.
29. Kulz AK, Meinzer S, Kopasz M, et al. (2008) Effects of tryptophan depletion on cognitive functioning, obsessive-compulsive symptoms and mood in obsessive-compulsive disorder: Preliminary results. Neuropsychobiology 56: 127-131.
30. Ledoux J, (2012) Rethinking the emotional brain. Neuron 73: 653-676.
31. Ledoux JE, (2014) Coming to terms with fear. Proc Natl Acad Sci U S A 111: 2871-2878.
32. Mcnaughton N, Corr PJ, (2004) A two-dimensional neuropsychology of defense: Fear/anxiety and defensive distance. Neurosci Biobehav Rev 28: 285-305.
33. Mobbs D, Petrovic P, Marchant JL, et al. (2007) When fear is near: Threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science 317: 1079-1083.
34. Sanislow CA, Pine DS, Quinn KJ, et al. (2010) Developing constructs for psychopathology research: Research domain criteria. J Abnorm Psychol 119: 631-639.
35. Sheehan DV, Lecrubier Y, Sheehan KH, et al. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (Suppl 20): 22-33; quiz 34-57.
36. Smeraldi E, Diaferia G, Erzegovesi S, et al. (1996) Tryptophan depletion in obsessive-compulsive patients. Biol Psychiatry 40: 398-402.
37. Smith KA, Fairburn CG, Cowen PJ, (1997) Relapse of depression after rapid depletion of tryptophan. Lancet 349: 915-919.
38. Spielberger CD, Gorsuch RI, Lushene RE, (1970) Manual for the State-Trait Anxiety Inventory. Palo Alto, California: Consulting Psychologists Press.
39. Starcevic V, (2014) Classification of anxiety disorders: Changes, conundrums and consequences. Aust N Z J Psychiatry 48: 1164-1165.
40. Young SN, Smith SE, Pihl RO, et al. (1985) Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology (Berl) 87: 173-177.